190 related articles for article (PubMed ID: 37433897)
1. Dual FGFR and VEGFR inhibition synergistically restrain hexokinase 2-dependent lymphangiogenesis and immune escape in intrahepatic cholangiocarcinoma.
Peng M; Li H; Cao H; Huang Y; Yu W; Shen C; Gu J
J Gastroenterol; 2023 Sep; 58(9):908-924. PubMed ID: 37433897
[TBL] [Abstract][Full Text] [Related]
2. Platelet-derived growth factor-D enables liver myofibroblasts to promote tumor lymphangiogenesis in cholangiocarcinoma.
Cadamuro M; Brivio S; Mertens J; Vismara M; Moncsek A; Milani C; Fingas C; Cristina Malerba M; Nardo G; Dall'Olmo L; Milani E; Mariotti V; Stecca T; Massani M; Spirli C; Fiorotto R; Indraccolo S; Strazzabosco M; Fabris L
J Hepatol; 2019 Apr; 70(4):700-709. PubMed ID: 30553841
[TBL] [Abstract][Full Text] [Related]
3. Qingjie Fuzheng Granule suppresses lymphangiogenesis in colorectal cancer via the VEGF-C/VEGFR-3 dependent PI3K/AKT pathway.
Huang B; Lu Y; Gui M; Guan J; Lin M; Zhao J; Mao Q; Lin J
Biomed Pharmacother; 2021 May; 137():111331. PubMed ID: 33578235
[TBL] [Abstract][Full Text] [Related]
4. Expression of VEGFR-3 in intrahepatic cholangiocarcinoma correlates with unfavorable prognosis through lymphangiogenesis.
Sha M; Jeong S; Chen XS; Tong Y; Cao J; Sun HY; Xia L; Xu N; Wang X; Han LZ; Xi ZF; Zhang JJ; Kong XN; Xia Q
Int J Biol Sci; 2018; 14(10):1333-1342. PubMed ID: 30123080
[No Abstract] [Full Text] [Related]
5. C/EBP-δ regulates VEGF-C autocrine signaling in lymphangiogenesis and metastasis of lung cancer through HIF-1α.
Min Y; Ghose S; Boelte K; Li J; Yang L; Lin PC
Oncogene; 2011 Dec; 30(49):4901-9. PubMed ID: 21666710
[TBL] [Abstract][Full Text] [Related]
6. FGF-dependent metabolic control of vascular development.
Yu P; Wilhelm K; Dubrac A; Tung JK; Alves TC; Fang JS; Xie Y; Zhu J; Chen Z; De Smet F; Zhang J; Jin SW; Sun L; Sun H; Kibbey RG; Hirschi KK; Hay N; Carmeliet P; Chittenden TW; Eichmann A; Potente M; Simons M
Nature; 2017 May; 545(7653):224-228. PubMed ID: 28467822
[TBL] [Abstract][Full Text] [Related]
7. MUC13 promotes intrahepatic cholangiocarcinoma progression via EGFR/PI3K/AKT pathways.
Tiemin P; Fanzheng M; Peng X; Jihua H; Ruipeng S; Yaliang L; Yan W; Junlin X; Qingfu L; Zhefeng H; Jian L; Zihao G; Guoxing L; Boshi S; Ming Z; Qinghui M; Desen L; Lianxin L
J Hepatol; 2020 Apr; 72(4):761-773. PubMed ID: 31837357
[TBL] [Abstract][Full Text] [Related]
8. Blocking Fibroblast Growth Factor receptor signaling inhibits tumor growth, lymphangiogenesis, and metastasis.
Larrieu-Lahargue F; Welm AL; Bouchecareilh M; Alitalo K; Li DY; Bikfalvi A; Auguste P
PLoS One; 2012; 7(6):e39540. PubMed ID: 22761819
[TBL] [Abstract][Full Text] [Related]
9. The CXCL12-CXCR4 chemokine pathway: a novel axis regulates lymphangiogenesis.
Zhuo W; Jia L; Song N; Lu XA; Ding Y; Wang X; Song X; Fu Y; Luo Y
Clin Cancer Res; 2012 Oct; 18(19):5387-98. PubMed ID: 22932666
[TBL] [Abstract][Full Text] [Related]
10. Sunitinib inhibits lymphatic endothelial cell functions and lymph node metastasis in a breast cancer model through inhibition of vascular endothelial growth factor receptor 3.
Kodera Y; Katanasaka Y; Kitamura Y; Tsuda H; Nishio K; Tamura T; Koizumi F
Breast Cancer Res; 2011 Jun; 13(3):R66. PubMed ID: 21693010
[TBL] [Abstract][Full Text] [Related]
11. Thrombospondin 1 and 2 along with PEDF inhibit angiogenesis and promote lymphangiogenesis in intrahepatic cholangiocarcinoma.
Carpino G; Cardinale V; Di Giamberardino A; Overi D; Donsante S; Colasanti T; Amato G; Mennini G; Franchitto M; Conti F; Rossi M; Riminucci M; Gaudio E; Alvaro D; Mancone C
J Hepatol; 2021 Dec; 75(6):1377-1386. PubMed ID: 34329660
[TBL] [Abstract][Full Text] [Related]
12. Foretinib inhibits angiogenesis, lymphangiogenesis and tumor growth of pancreatic cancer in vivo by decreasing VEGFR-2/3 and TIE-2 signaling.
Chen HM; Tsai CH; Hung WC
Oncotarget; 2015 Jun; 6(17):14940-52. PubMed ID: 25909285
[TBL] [Abstract][Full Text] [Related]
13. Total saponins of panaxnotoginseng promotes lymphangiogenesis by activation VEGF-C expression of lymphatic endothelial cells.
Li J; Chen Y; Zhang L; Xing L; Xu H; Wang Y; Shi Q; Liang Q
J Ethnopharmacol; 2016 Dec; 193():293-302. PubMed ID: 27553977
[TBL] [Abstract][Full Text] [Related]
14. A potential small-molecule synthetic antilymphangiogenic agent norcantharidin inhibits tumor growth and lymphangiogenesis of human colonic adenocarcinomas through blocking VEGF-A,-C,-D/VEGFR-2,-3 "multi-points priming" mechanisms in vitro and in vivo.
Li XP; Jing W; Sun JJ; Liu ZY; Zhang JT; Sun W; Zhu W; Fan YZ
BMC Cancer; 2015 Jul; 15():527. PubMed ID: 26187792
[TBL] [Abstract][Full Text] [Related]
15. c-Myc promotes lymphatic metastasis of pancreatic neuroendocrine tumor through VEGFC upregulation.
Chang TM; Chu PY; Hung WC; Shan YS; Lin HY; Huang KW; Chang JS; Chen LT; Tsai HJ
Cancer Sci; 2021 Jan; 112(1):243-253. PubMed ID: 33128283
[TBL] [Abstract][Full Text] [Related]
16. Lymphangiogenesis requires Ang2/Tie/PI3K signaling for VEGFR3 cell-surface expression.
Korhonen EA; Murtomäki A; Jha SK; Anisimov A; Pink A; Zhang Y; Stritt S; Liaqat I; Stanczuk L; Alderfer L; Sun Z; Kapiainen E; Singh A; Sultan I; Lantta A; Leppänen VM; Eklund L; He Y; Augustin HG; Vaahtomeri K; Saharinen P; Mäkinen T; Alitalo K
J Clin Invest; 2022 Aug; 132(15):. PubMed ID: 35763346
[TBL] [Abstract][Full Text] [Related]
17. Collaborative interplay between FGF-2 and VEGF-C promotes lymphangiogenesis and metastasis.
Cao R; Ji H; Feng N; Zhang Y; Yang X; Andersson P; Sun Y; Tritsaris K; Hansen AJ; Dissing S; Cao Y
Proc Natl Acad Sci U S A; 2012 Sep; 109(39):15894-9. PubMed ID: 22967508
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of lymphatic proliferation by the selective VEGFR-3 inhibitor SAR131675 ameliorates diabetic nephropathy in db/db mice.
Hwang SD; Song JH; Kim Y; Lim JH; Kim MY; Kim EN; Hong YA; Chung S; Choi BS; Kim YS; Park CW
Cell Death Dis; 2019 Mar; 10(3):219. PubMed ID: 30833548
[TBL] [Abstract][Full Text] [Related]
19. Docetaxel facilitates lymphatic-tumor crosstalk to promote lymphangiogenesis and cancer progression.
Harris AR; Perez MJ; Munson JM
BMC Cancer; 2018 Jul; 18(1):718. PubMed ID: 29976154
[TBL] [Abstract][Full Text] [Related]
20. Vascular endothelial growth factor receptor-3 directly interacts with phosphatidylinositol 3-kinase to regulate lymphangiogenesis.
Coso S; Zeng Y; Opeskin K; Williams ED
PLoS One; 2012; 7(6):e39558. PubMed ID: 22745786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]